Information for the public, researchers, academics and clinicians on COVID-19 research taking place on the Cambridge Biomedical Campus.
A partnership, funded and supported by the NIHR, between Cambridge University Hospitals and the University of Cambridge to deliver ground-breaking research that benefits patients.
Covering 15 different health themes and supported by world-leading experts, our research helps deliver better medicines and treatments for the NHS. Find out more about the research we support.
Our research is strengthened through collaboration and partnership with industry – from small biotechs to multinational pharmaceuticals. Find out more about our work with industry.
We put patients at the heart of our research. Help us to make sure research meets patients’ needs. There are lots of ways you can get involved – find out more today.
State-of-the-art infrastructure and facilities to support research delivery: all located on a single site just one hour from London. Find out more about the facilities on site.
The NIHR Cambridge BRC is delighted that three of our researchers have been elected as Fellows of the Academy of Medical Sciences.
Theme leads Professor Menna Clatworthy and Professor Ludovic Vallier, together with Read more
The PROLIFIC study (ChemoPROphyLaxIs For covId-19 infeCtious disease) aims to determine whether hydroxychloroquine (HCQ), a widely used anti-malarial drug, is effective at preventing or reducing COVID-19 infection in frontline healthcare workers.Read more
A new national study, supported by the NIHR Cambridge Biomedical Research Centre and the Cambridge Clinical Trials Unit will test whether two drugs that are already in use to treat other immune-related conditions Read more